Literature DB >> 26622846

Hepatocellular carcinoma presenting as thoracic spinal canal metastasis with no clinical primary foci: A report of a rare case and review of the literature.

Runzhe Chen1, Zengxin Gao2, Xiaotao Wu2, Jos L Campbell3, Pei Zhang2, Baoan Chen1.   

Abstract

Hepatocellular carcinoma (HCC) is the third most common malignant tumor worldwide and has a poor survival rate. The poor prognosis can be attributed to several of the characteristics of HCC, such as fast infiltrating growth, early-stage metastasis, high-grade malignancy and poor therapeutic efficacy. The current study presents a case of HCC that was metastatic to the spinal canal with an unknown primary site and discusses the diagnostic probabilities. The patient was a 48-year-old female who presented with chest paraesthesis of the back and numbness of the right lower limb. Computed tomography (CT) and magnetic resonance imaging indicated a possible lipomyoma in the thoracic spinal canal. Surgery was performed to remove the mass and the post-operative pathological diagnosis indicated a moderately-differentiated HCC. Subsequent abdominal CT scans and B-mode ultrasound failed to localize the primary foci in the liver and the tumor markers were normal. The patient had no history of chronic liver disease in the past. The patient refused any further examinations after surgery and was discharged from hospital. A post-operative follow-up 1.5 years later found that the patient was healthy and that the level of discomfort had been significantly reduced following the surgery. HCC presenting as thoracic spinal canal metastasis with an unknown primary site is extremely rare. The present study additionally reports the results of a literature review and provides a rational deduction for the unknown primary foci of HCC.

Entities:  

Keywords:  hepatocellular carcinoma; metastasis; primary foci

Year:  2015        PMID: 26622846      PMCID: PMC4580039          DOI: 10.3892/ol.2015.3569

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  12 in total

Review 1.  Hepatocellular carcinoma review: current treatment, and evidence-based medicine.

Authors:  Ali Raza; Gagan K Sood
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

Review 2.  Hepatocellular carcinoma: A global view.

Authors:  Ju Dong Yang; Lewis R Roberts
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-07-13       Impact factor: 46.802

Review 3.  Guide for diagnosis and treatment of hepatocellular carcinoma.

Authors:  Magdy Hamed Attwa; Shahira Aly El-Etreby
Journal:  World J Hepatol       Date:  2015-06-28

4.  Molecular genetics of hepatocellular neoplasia.

Authors:  Shilpa Jain; Shashideep Singhal; Peng Lee; Ruliang Xu
Journal:  Am J Transl Res       Date:  2010-01-23       Impact factor: 4.060

Review 5.  Management of small hepatocellular carcinoma: a review of transplantation, resection, and ablation.

Authors:  William R Jarnagin
Journal:  Ann Surg Oncol       Date:  2010-04-20       Impact factor: 5.344

6.  Switching benchmarks in cancer of unknown primary: from autopsy to microarray.

Authors:  George Pentheroudakis; Vassilios Golfinopoulos; Nicholas Pavlidis
Journal:  Eur J Cancer       Date:  2007-08-14       Impact factor: 9.162

Review 7.  New perspectives and strategy research biomarkers for hepatocellular carcinoma.

Authors:  Raphaël Saffroy; Patrick Pham; Maâmar Reffas; Mohamed Takka; Antoinette Lemoine; Brigitte Debuire
Journal:  Clin Chem Lab Med       Date:  2007       Impact factor: 3.694

Review 8.  Hepatocellular carcinoma: clinical frontiers and perspectives.

Authors:  Jordi Bruix; Gregory J Gores; Vincenzo Mazzaferro
Journal:  Gut       Date:  2014-02-14       Impact factor: 23.059

Review 9.  Cancer of unknown primary: progress in the search for improved and rapid diagnosis leading toward superior patient outcomes.

Authors:  F A Greco; K Oien; M Erlander; R Osborne; G Varadhachary; J Bridgewater; D Cohen; H Wasan
Journal:  Ann Oncol       Date:  2011-06-27       Impact factor: 32.976

10.  Neuroendocrine cell carcinoma of unknown primary arising in long standing history of multiple sclerosis.

Authors:  Stergios Boussios; Vasiliki Kostadima; Anna Batistatou; Ioannis Tourkantonis; George Fotopoulos; Maria I Argyropoulou; Nicholas Pavlidis
Journal:  Case Rep Oncol Med       Date:  2015-03-24
View more
  1 in total

1.  Sex-specific analysis post-liver transplantation in hemochromatosis with aplastic anemia and hepatocellular carcinoma.

Authors:  Paul Adams; Christopher Howlett; Anargyros Xenocostas; Subrata Chakrabarti
Journal:  Hepatol Commun       Date:  2017-11-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.